Gefitinib vs Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Variant Lung Cancer—Long-Term Results of a Randomized Clinical Trial

Post time 2024-4-26 13:46:40

journal：JAMA Oncology

Authors：Vanita Noronha; Vijay Patil; Nandini Menon; Minit Shah; Anuradha Chougule; Zoya Peelay; Kumar Prabhash

Published date：--

DOI：10.1001/jamaoncol.2024.0584

PDF link：https://jamanetwork.com/journals ... 713552323.34254.pdf

Article link：http://dx.doi.org/10.1001/jamaoncol.2024.0584

Article Source：American Medical Association (AMA)。

Remark：

Post time 2024-4-26 13:46:41

: This post has been completed
Completed attachments will be deleted within 24 hours.

[JAMA] Gefitinib vs Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Variant Lung Cancer—Long-Term Results of a Randomized Clinical Trial

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[JAMA] Gefitinib vs Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Variant Lung Cancer—Long-Term Results of a Randomized Clinical Trial Copy